CFLPA protests suspension of defensive back Loucheiz Purifoy
Global News
The league suspended Purifoy on Friday.
The CFL Players’ Association says it “strongly protests” the CFL’s suspension of defensive back Loucheiz Purifoy for violating its drug policy.
Hours before the CFL announced it was suspending Purifoy for two games, the Edmonton Elks released the nine-year veteran after two seasons with the club.
The league suspended Purifoy on Friday, saying he tested positive for amphetamine, a stimulant that can be used to treat such disorders as attention-deficit/hyperactivity disorder (ADHD).
The CFLPA said in a statement Monday that Purifoy tested positive for Adderall, which contains amphetamine, in August 2024. The union added Adderall is a “commonly-prescribed medication for ADHD.”
The CFLPA said Purifoy not only addressed the positive test but also took part in a comprehensive medical evaluation.
That included a psychologist’s diagnosis, which the union said confirmed the player’s diagnosis (for ADHD) and established “a medical basis for prescribed treatment with Adderall going forward.”
“Despite this, the CFL instructed the Edmonton Elks to not apply for an Emergency Therapeutic Use Exemption (TUE), which would have allowed an independent medical review of his case,” the union said. “Instead, the league chose a path ensuring suspension, disregarding relevant medical facts.
“The CFL’s public stance on mental health is contradicted by its actions in this case. Rather than supporting a player facing a verified medical challenge, the league’s approach has caused unnecessary harm to Mr. Purifoy’s reputation and career.”